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1. Introduction 
The photo-oxidation f bilimbin IXa (fig. 3:1) is 
of current interest in the treatment of neonatal 
jaundice (hyperbilirubinemia)by phototherapy [1, 2]. 
Untreated neonatal hyperbilirubinemia m y lead to 
cerebral palsy or even death. Since Cremer et al. [3] 
observed that exposing the jaundiced infant to intense 
light lowered elevated bilirubin levels in the newborn, 
phototherapy of the icteric infant has gained in popu- 
larity. However, it has also become highly controversial 
[1,2] due mainly to 2 possible inherent dangers: i)
the untoward effects of prolonged illumination and 
ii) uncertainty over the structures of the photo- 
products and their potential toxicities. Ostrow [4-6] 
and Schmid [6] have indicated, and we have since 
found [7], that the photo-destruction of bilirubin 
gives biliverdin IXa (fig. 3:3). Moreover, the photo- 
products from 1 and 3 (fig. 3) exhibit a similar thin 
layer chromatographic behavior [4, 7]. Since no firm 
structural information has yet appeared on the photo- 
degradation products from biliverdin, we wish to 
report here on the first isolation and structure proof 
of a biliverdin photo-product, methylvinylmaleimide 
(fig. 3:2). 
2. Materials and methods 
Crude biliverdin IXa was prepared in 90% yield by 
controlled oxidation of bilirubin IX(x (100 mg, pur- 
chased from Matheson, Coleman and Bell) using 
benzoquinone (101 mg) in 50 ml of dimethyl sulfox- 
ide-acetic acid (9:1 v/v) according to the procedure of 
Bonnett and McDonagh [9]. The pure biliverdin IXa 
usedin this work was obtained in an overall 28% yield 
after column chromatography on silica gel (E. Merck, 
Darmstadt, 70-325 mesh)using 1:1 v/v CHC13- 
CHaOH as eluate. On thin layer chromatography 
(TLC) (M. Woelm, Eschwege, CH3C1-CH3OH 5 : 1 
v/v) 1 moved as one green spot, Rf 0.50, with very 
slight traces of the Ilia and XIIIa isomers (Rf's 0.53 
and 0.46, respectively) [8] which are the principal 
isomeric ontaminants of commercial bilirubin IXu 
[10]. 
A 0.66 mmolar methanolic solution of biliverdin 
was irradiated for 132 hr in an immersion well ap- 
paratus using a 500 W Westinghouse tungsten halogen 
lamp (500 Q/CL) at 120 V while bubbling a rapid 
stream of oxygen through the solution. No known 
singlet oxygen sensitizers [ 11 ] were added. Changes 
in the visible ultraviolet spectrum (fig. 1) were recorded 
during the course of photolysis on a Cary 14 spectro- 
photometer. The formation of photo-degradation pro- 
ducts was detected by TLC (fig. 2) as above for 3. Pre- 
parative TLC (M. Woelm, Eschwege, 1ram, CHC13) 
of the crude photolysate after evaporation of the 
solvent in vacuo separated the products. All mass 
spectra were determined on a CEC491 MS-21 mass 
spectrometer and nuclear magnetic resonance (NMR) 
spectra were run on a Varian T-60 instrument. 
3. Results and discussion 
The known [5] photo-destructibility of biliverdin 
in the presence of oxygen is fully evident in the 
spectral changes recorded in fig. 1. At our high con- 
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Fig. 1. Visible-ultraviolet spectral changes recorded inmethanol solvent during the photo-oxidation f bfliverdin. Curves are label- 
led with irradiation times. 
centrations of 1, the intensity maxima in the vicinities 
of 660 and 375 nm gradually shrink (0-132 hr) 
leaving only the maximum near 275 nm (which may 
be found even at the onset of photolysis) and end 
absorption. Concomitant with these spectral changes, 
the appearance of new products can be shown by fol- 
lowing the photo-destruction using TLC (fig. 2). At 
least 2 new colored substances become vident early 
(8 hr) in the photolysis. Eventually (46 hr) 7 or more 
new substances appear. As 1 is consumed (84 hr), even 
some of the initially formed photo-products (Rf"~ 0.5) 
begin to disappear until at the termination of the reac- 
tion (132 hr) 1 and the initially formed photo-pro- 
ducts (Rf~ 0.5) are only faintly present and there 
remain essentially non-polar (Rf~ 0.9) and very polar 
(Rf~ 0.0) products. 
After 46 hr of irradiation, the characteristic pale 
blue fluorescence [12] of methylvinylmaleimide (2),
Rf 0.88, becomes noticeable. On the basis of this visual 
method of detection, the concentration f 2 in the 
photolysis mixture increases through 132 hr of irradi- 
ation at which time the reaction was terminated. 
After evaporation of the solvent in vacuo and prepara- 
tive TLC of the crude photolysate, a 10% yield of 2 
was obtained. Its structure was proved by its mp 
82-4 ° (mp 84-5 ° [11] ); mass spectrum; m/e 
(relative intensity):137 (39%) [M+], 119 (2%), 109 
(7%), 94 (5%) and 66 (100%); and its NMR spectrum 
(60 MHz, CDCI3) 8 2.05 (s, 3H, CH3), 5.70 (m, 1H, 
~H=)  and 6.45 (m, 2H, =CH 2 ) ppm. Methylvinyl- 
maleimide isnot formed during a control experiment 
omitting light. 
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Fig. 2. Thin layer chromatogram (CHC13 -CH3OH, 5 : 1 v/v) of biliverdin and its photo-oxidation products during the course of ir- 
radiation. Colors and/or UV fluorescence (*) are as indicated: (0 hr), 1: pale green, 2: dark green, 3: pale green; (8 hr), 1: violet, 
2: pale green, 3: dark green, 4: pale green, 5: yellow; (22 hr), 1: dark blue (*), 2: violet, 3: pale green, 4: dark green, 5: orange, 
6: pale green, 7: violet, 8: yellow, 9: yellow; (46 hr), 1 : dark blue (*), 2: pale blue (*), 3 : violet, 4: pale green, 5 : dark green, 6: 
orange, 7: olive, 8: violet, 9: yellow, 10: yellow; (84 hr), 1: dark blue (*), 2: pale blue (*), 3: yellow, 4: green, 5: orange, 6: 
brown, 7: yellow, 8: tan; (132 hr), 1: dark blue (*), 2: pale blue (*), 3: yellow, 4: green, 5: orange, 6: pale yellow, 7: tan. At time 
0 hr spots 1,2 and 3 are biliverdin lllc~, IXa and XIIlr, in that order [7]. 
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Fig. 3. 
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Methylvinylmaleimide s vidently formed by 
cleavage of rings A and B of 3, presumably via 
photo-oxidation f the enamine-like/3 and 5 bridges 
[13, 14]. Its isolation is remarkable on 2 grounds: 
i) the known photo-lability of the vinyl groups of 
protoporphyrin [15] and ii) the established tendency 
of 2 to polymerize [12, 16]. It is of special interest 
to note that 2 does not exhibit he usual enzyme 
toxicity associated with maleimides [17, 18]. This 
finding suggests that should 2 be formed in vivo 
during phototherapy it would not be toxic. 
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